BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Press Releases

  X4 Pharmaceuticals Announces Strategic Restructuring to Drive Value and Maximize Opportunity for Mavorixafor in Chronic Neutropenia

  February 6, 2025

   · 

  6 min read
• Press Releases

  Atsena Therapeutics to Present ATSN-201 Safety and Efficacy Data at The Macula Society’s 48th Annual Meeting

  February 6, 2025

   · 

  3 min read
• Press Releases

  Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal Trial

  February 6, 2025

   · 

  6 min read
• Press Releases

  Ashvattha to Present at Upcoming Angiogenesis, Exudation, and Degeneration 2025 and BIO CEO Conferences

  February 6, 2025

   · 

  2 min read
• Press Releases

  Dr. Reddy’s enters into collaboration with Henlius for commercialization of HLX15 (daratumumab), a biosimilar candidate to Darzalex® & Darzalex Faspro® in the U.S., and Europe

  February 6, 2025

   · 

  7 min read
• Press Releases

  Alignment Healthcare to Announce Fourth Quarter and Full-Year 2024 Financial Results and Host Conference Call Thursday, Feb. 27, 2025

  February 6, 2025

   · 

  1 min read
• Press Releases

  Tonix Pharmaceuticals Announces Positive Topline Results from Phase 1 Trial for TNX-1500, a Next Generation anti-CD40L mAb Candidate for Prevention of Kidney Transplant Rejection and Treatment of Autoimmune Diseases

  February 6, 2025

   · 

  13 min read
• Press Releases

  CAMP4 to Participate in Upcoming Investor Conferences

  February 6, 2025

   · 

  1 min read
• Press Releases

  Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

  February 6, 2025

   · 

  1 min read
• Press Releases

  Bracco Imaging Receives FDA Fast Track Designation for BR55, Ultrasound Molecular Imaging Agent for the Detection of Active Bowel Inflammation in Crohn’s Disease

  February 6, 2025

   · 

  6 min read